Global Vaccine Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Vaccine Market
The research report studies the Vaccine market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Vaccine Scope and Segment
The global Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
by Application, this report covers the following segments
For Adult
For Child
Global Vaccine market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Vaccine key players in this market include:
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties

TABLE OF CONTENT

1 Market Overview of Vaccine
1.1 Vaccine Market Overview
1.1.1 Vaccine Product Scope
1.1.2 Vaccine Market Status and Outlook
1.2 Global Vaccine Market Size Overview by Region 2016 VS 2030VS 2027
1.3 Global Vaccine Market Size by Region (2016-2027)
1.4 Global Vaccine Historic Market Size by Region (2016-2030)
1.5 Global Vaccine Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Vaccine Market Size (2016-2027)
1.6.1 North America Vaccine Market Size (2016-2027)
1.6.2 Europe Vaccine Market Size (2016-2027)
1.6.3 Asia-Pacific Vaccine Market Size (2016-2027)
1.6.4 Latin America Vaccine Market Size (2016-2027)
1.6.5 Middle East & Africa Vaccine Market Size (2016-2027)

2 Vaccine Market Overview by Type
2.1 Global Vaccine Market Size by Type: 2016 VS 2030 VS 2027
2.2 Global Vaccine Historic Market Size by Type (2016-2030)
2.3 Global Vaccine Forecasted Market Size by Type (2022-2027)
2.4 Varicella Vaccine
2.5 Influenza Vaccine
2.6 Polio Vaccine
2.7 Hepatitis A Vaccine
2.8 Rabies Vaccine
2.9 BCG Vaccine
2.10 Hepatitis B
2.11 Pertussis, Diphtheria, Tetanus
2.12 Pneumococcal

3 Vaccine Market Overview by Application
3.1 Global Vaccine Market Size by Application: 2016 VS 2030 VS 2027
3.2 Global Vaccine Historic Market Size by Application (2016-2030)
3.3 Global Vaccine Forecasted Market Size by Application (2022-2027)
3.4 For Adult
3.5 For Child

4 Vaccine Competition Analysis by Players
4.1 Global Vaccine Market Size by Players (2016-2030)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine as of 2020)
4.3 Date of Key Players Enter into Vaccine Market
4.4 Global Top Players Vaccine Headquarters and Area Served
4.5 Key Players Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 AstraZeneca
5.1.1 AstraZeneca Profile
5.1.2 AstraZeneca Main Business
5.1.3 AstraZeneca Vaccine Products, Services and Solutions
5.1.4 AstraZeneca Vaccine Revenue (US$ Million) & (2016-2030)
5.1.5 AstraZeneca Recent Developments
5.2 BioNTech
5.2.1 BioNTech Profile
5.2.2 BioNTech Main Business
5.2.3 BioNTech Vaccine Products, Services and Solutions
5.2.4 BioNTech Vaccine Revenue (US$ Million) & (2016-2030)
5.2.5 BioNTech Recent Developments
5.3 Boehringer-Ingelheim
5.3.1 Boehringer-Ingelheim Profile
5.3.2 Boehringer-Ingelheim Main Business
5.3.3 Boehringer-Ingelheim Vaccine Products, Services and Solutions
5.3.4 Boehringer-Ingelheim Vaccine Revenue (US$ Million) & (2016-2030)
5.3.5 CCBIO Recent Developments
5.4 CCBIO
5.4.1 CCBIO Profile
5.4.2 CCBIO Main Business
5.4.3 CCBIO Vaccine Products, Services and Solutions
5.4.4 CCBIO Vaccine Revenue (US$ Million) & (2016-2030)
5.4.5 CCBIO Recent Developments
5.5 CSL
5.5.1 CSL Profile
5.5.2 CSL Main Business
5.5.3 CSL Vaccine Products, Services and Solutions
5.5.4 CSL Vaccine Revenue (US$ Million) & (2016-2030)
5.5.5 CSL Recent Developments
5.6 CureVac
5.6.1 CureVac Profile
5.6.2 CureVac Main Business
5.6.3 CureVac Vaccine Products, Services and Solutions
5.6.4 CureVac Vaccine Revenue (US$ Million) & (2016-2030)
5.6.5 CureVac Recent Developments
5.7 Elanco
5.7.1 Elanco Profile
5.7.2 Elanco Main Business
5.7.3 Elanco Vaccine Products, Services and Solutions
5.7.4 Elanco Vaccine Revenue (US$ Million) & (2016-2030)
5.7.5 Elanco Recent Developments
5.8 GSK
5.8.1 GSK Profile
5.8.2 GSK Main Business
5.8.3 GSK Vaccine Products, Services and Solutions
5.8.4 GSK Vaccine Revenue (US$ Million) & (2016-2030)
5.8.5 GSK Recent Developments
5.9 Hulan Bio
5.9.1 Hulan Bio Profile
5.9.2 Hulan Bio Main Business
5.9.3 Hulan Bio Vaccine Products, Services and Solutions
5.9.4 Hulan Bio Vaccine Revenue (US$ Million) & (2016-2030)
5.9.5 Hulan Bio Recent Developments
5.10 Indian Immunologicals
5.10.1 Indian Immunologicals Profile
5.10.2 Indian Immunologicals Main Business
5.10.3 Indian Immunologicals Vaccine Products, Services and Solutions
5.10.4 Indian Immunologicals Vaccine Revenue (US$ Million) & (2016-2030)
5.10.5 Indian Immunologicals Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Vaccine Products, Services and Solutions
5.11.4 Merck Vaccine Revenue (US$ Million) & (2016-2030)
5.11.5 Merck Recent Developments
5.12 Minhai Biotechnology
5.12.1 Minhai Biotechnology Profile
5.12.2 Minhai Biotechnology Main Business
5.12.3 Minhai Biotechnology Vaccine Products, Services and Solutions
5.12.4 Minhai Biotechnology Vaccine Revenue (US$ Million) & (2016-2030)
5.12.5 Minhai Biotechnology Recent Developments
5.13 Mitsubishi Tanabe Pharma
5.13.1 Mitsubishi Tanabe Pharma Profile
5.13.2 Mitsubishi Tanabe Pharma Main Business
5.13.3 Mitsubishi Tanabe Pharma Vaccine Products, Services and Solutions
5.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue (US$ Million) & (2016-2030)
5.13.5 Mitsubishi Tanabe Pharma Recent Developments
5.14 Moderna Therapeutics
5.14.1 Moderna Therapeutics Profile
5.14.2 Moderna Therapeutics Main Business
5.14.3 Moderna Therapeutics Vaccine Products, Services and Solutions
5.14.4 Moderna Therapeutics Vaccine Revenue (US$ Million) & (2016-2030)
5.14.5 Moderna Therapeutics Recent Developments
5.15 Mylan
5.15.1 Mylan Profile
5.15.2 Mylan Main Business
5.15.3 Mylan Vaccine Products, Services and Solutions
5.15.4 Mylan Vaccine Revenue (US$ Million) & (2016-2030)
5.15.5 Mylan Recent Developments
5.16 Plumbline Life Sciences
5.16.1 Plumbline Life Sciences Profile
5.16.2 Plumbline Life Sciences Main Business
5.16.3 Plumbline Life Sciences Vaccine Products, Services and Solutions
5.16.4 Plumbline Life Sciences Vaccine Revenue (US$ Million) & (2016-2030)
5.16.5 Plumbline Life Sciences Recent Developments
5.17 Sanofi
5.17.1 Sanofi Profile
5.17.2 Sanofi Main Business
5.17.3 Sanofi Vaccine Products, Services and Solutions
5.17.4 Sanofi Vaccine Revenue (US$ Million) & (2016-2030)
5.17.5 Sanofi Recent Developments
5.18 Translate Bio
5.18.1 Translate Bio Profile
5.18.2 Translate Bio Main Business
5.18.3 Translate Bio Vaccine Products, Services and Solutions
5.18.4 Translate Bio Vaccine Revenue (US$ Million) & (2016-2030)
5.18.5 Translate Bio Recent Developments
5.19 Walvax Biotechnology
5.19.1 Walvax Biotechnology Profile
5.19.2 Walvax Biotechnology Main Business
5.19.3 Walvax Biotechnology Vaccine Products, Services and Solutions
5.19.4 Walvax Biotechnology Vaccine Revenue (US$ Million) & (2016-2030)
5.19.5 Walvax Biotechnology Recent Developments
5.20 Wuhan Institute of Biological Products
5.20.1 Wuhan Institute of Biological Products Profile
5.20.2 Wuhan Institute of Biological Products Main Business
5.20.3 Wuhan Institute of Biological Products Vaccine Products, Services and Solutions
5.20.4 Wuhan Institute of Biological Products Vaccine Revenue (US$ Million) & (2016-2030)
5.20.5 Wuhan Institute of Biological Products Recent Developments
5.21 Zoties
5.21.1 Zoties Profile
5.21.2 Zoties Main Business
5.21.3 Zoties Vaccine Products, Services and Solutions
5.21.4 Zoties Vaccine Revenue (US$ Million) & (2016-2030)
5.21.5 Zoties Recent Developments

6 North America
6.1 North America Vaccine Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Vaccine Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Vaccine Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Vaccine Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Vaccine Market Dynamics
11.1 Vaccine Industry Trends
11.2 Vaccine Market Drivers
11.3 Vaccine Market Challenges
11.4 Vaccine Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Choose License Type

Checkout Inquiry Sample